Kura Oncology Inc. (KURA)
6.38
-0.22 (-3.33%)
At close: Apr 01, 2025, 3:59 PM
Kura Oncology Ratios Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
| PE Ratio | -4.31 | -6.9 | -6.11 | -7.15 | -19.38 | -9.13 | -8.17 | -10.03 | -4 | -3.69 |
| PEG Ratio | 1.50 | -2.8 | -1.71 | -0.43 | -1.72 | 0.75 | -0.62 | -2.95 | 0.11 | 0.04 |
| PS Ratio | 13.93 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | 1.81 | 2.65 | -1.46 | -2.15 | -5.73 | -2.71 | -3.3 | 4.45 | 1.94 | 1.02 |
| P/FCF Ratio | 5.61 | -8.42 | -7.51 | -8.79 | -24.08 | -10.53 | -10.15 | -12.5 | -4.35 | -4.64 |
| P/OCF Ratio | 5.59 | -8.44 | -7.55 | -8.88 | -24.82 | -10.53 | -10.15 | -12.5 | -4.35 | -4.65 |
| OCF/S Ratio | 2.49 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | 0.04 | 0.04 | -0.02 | -0.02 | -0.05 | -0.04 | -0.05 | 0.09 | 0.13 | n/a |
| Quick Ratio | 9.46 | 12.26 | 18.56 | 23.26 | 24.49 | 15.39 | 13.31 | 9.43 | 12.62 | 17.18 |
| Current Ratio | 9.46 | 12.26 | 18.56 | 23.26 | 24.49 | 15.39 | 13.31 | 9.43 | 12.62 | 17.18 |
| Asset Turnover | 0.07 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | -119.33 | -107.04 | -614.08 | -318.4 | -159.33 | -116.34 | -64.83 | -40.63 | -49.16 | -271.19 |
| Return on Equity (ROE) | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Return on Assets (ROA) | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Return on Capital (ROIC) | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 100.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | -322.89% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | -319.15% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | -358.55% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | 248.40% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | -314.57% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |